We investigated the possibility that dissolved mannan polysaccharide from Candida may have an inhibitory influence on the host defense mechanisms associated with neutrophils and thereby contribute to the pathogenesis of candidoses. We created a model for this hypothesis by using mannan derived from bakers' yeast (Saccharomyces cerevisiae) and mannan isolated from the serum of a patient with chronic mucocutaneous candidosis. We observed that these mannans inhibited the respiratory burst and release of myeloperoxidase stimulated by phagocytosis of serum-opsonized zymosan in vitro. Mannan did not inhibit release of three other lysosomal enzymes. The selective inhibition of release of myeloperoxidase was attributable to a carbohydrate-binding property of the enzyme, with the mannan causing co-sedimentation of the enzyme with the cellular fraction.
Infection by Candida most often occurs as a consequence of compromised host defense functions (1, 5, 17) . Such compromised defense functions may occur in association with certain disease states or after various medical manipulations. The information available in several recent reports indicates that once established, the yeast itself may also contribute to the loss of host defense functions. We (R. D. Nelson, R. T.
McCormack, M. J. Herron, and R. L. Simmons, RES J. Reticuloendothel. Soc. 24:15a, 1978 ) and others (8) have reported that yeast cell wall mannan polysaccharide inhibits cell-mediated immunity, as measured by the lymphoproliferative response of mononuclear leukocytes to soluble antigen in vitro. Other investigators have described inhibitory influences of Candida or its components on the microbicidal function of the neutrophils (10, 23) . Thus, yeast-associated mannan or mannan released into tissue fluid or plasma may provide a mechanism for local or systemic modulation of host defense responses.
Because of the potential significance of yeastmediated modulation of the host defense system to the pathogenesis of chronic candidoses, we tested the effect of mannans derived from Saccharomyces cerevisiae and from serum from a patient with chronic mucocutaneous candidosis on human neutrophil migratory, respiratory, and secretory responses. We found that these mannans selectively inhibited accumulation of lysosomal myeloperoxidase in the suspending medium. This result led us to the discovery that myeloperoxidase has the ability to bind to certain carbohydrates. We propose that this previously unrecognized carbohydrate-binding property of myeloperoxidase may provide the mechanism for adsorption of this enzyme to microorganisms (14, 25) and thereby play an important role in the microbicidal activity of this enzyme (13, 16) .
MATERIALS AND METHODS
Isolation of neutrophils. Blood was drawn from healthy volunteers into heparinized syringes (10 U/ ml), and neutrophils were isolated by the method of Ferrante and Thong (6) . The cell suspension medium used throughout this study was Dulbecco phosphatebuffered saline (PBS) (GIBCO Laboratories, Grand Island, N.Y.).
Assays of neutrophil functions. Spontaneous and chemotactic migratory responses were assessed by the migration-under-agarose method, as previously described (21) . The synthetic peptide cytotaxin Nformyl-methionyl-leucyl-phenylalanine (CalbiochemBehring Corp., La Jolla, Calif.) was used at a concentration of 10-7 M. Specific binding of N-formyl-methionyl-leucyl-[3H]phenylalanine (New England Nuclear Corp., Boston, Mass.) was measured as previously described (19) .
The respiratory burst response was measured as superoxide-mediated reduction of cytochrome c (Sigma Chemical Co., St. Louis, Mo.), as described by DeChatelet et al. (3) . Alternatively, this response was monitored by measuring chemiluminescence, as previously described (20) . The stimulus (serum-opsonized zymosan) was prepared as described by Wardlaw and trophils and 1.25 mg of zymosan in PBS. These two assays were conducted at 370C and at ambient temperature, respectively. The secretion of four lysosomal enzymes (acid phosphatase, beta-glucuronidase, lysozyme, and myeloperoxidase) was determined by incubating tubes containing 5 x 10' neutrophils and 1.25 mg of opsonized zymosan in 1.0 ml of PBS at 37°C for the times indicated below. The secretory response was stopped by transferring the tubes to ice water. Cells were removed by centrifugation, and the supernatant fluids were assayed for lysosomal enzyme activities.
Acid phosphatase and beta-glucuronidase were assayed by using diagnostic kits 104 and 325 (Sigma), respectively. Lysozyme was assayed by using a reagent kit from Worthington Diagnostics, Freehold, N.J. Myeloperoxidase was quantitated by the method of West et al. (29) . To determine enzyme release as a percentage of the total available enzyme activity, the latter value was obtained by measuring the enzyme activity in a lysate prepared by sonicating cells in 3 1 M ethanolamine. The Sepharose was then washed sequentially with acetate buffer, 0.5 M NaCl, borate buffer, and 0.5 M NaCl. Ethanolamine-blocked beads were also prepared and served as controls to monitor the ability of myeloperoxidase to bind directly to Sepharose.
Myeloperoxidase was isolated by using concanavalin A-agarose, essentially as described by Merrill (18) . Neutrophils were lysed by sonication, and the resulting lysate was mixed with concanavalin A-agarose for 30 min at ambient temperature. The enzymeagarose mixture was recovered by centrifugation at 1,200 x g for 5 min and washed twice in PBS. The enzyme bound to the agarose was released by adding 1 volume of a solution containing 40 mg of alphamethyl-D-mannoside per ml in PBS for 30 min. After centrifugation to remove the bead fraction, the supernatant fluid was dialyzed against PBS to remove the sugar. Subsequent chromatography of the concanavalin A-adsorbent material with a Sephadex G-150 column and PBS as the elution buffer produced a single, homogeneous peak exhibiting myeloperoxidase activity. The myeloperoxidase isolated was not otherwise tested exhaustively for contaminating glycoprotein.
Isolation of mannan from patient serum. Patient mannan was prepared from serum obtained from a 37-year-old male who developed oral mucocutaneous 
RESULTS
Effect of mannan on multiple neutrophil functions. Figure 1 shows the influence of S. cerevisiae mannan on human neutrophil migratory, respiratory, and secretory functions. In these experiments, the concentration of S. cerevisiae mannan was limited to 1 mg/ml. We determined that S. cerevisiae mannan at this concentration had no measureable cytotoxic effect, as determined by assessing the release of cytoplasmic lactate dehydrogenase. Neutrophils suspended in medium containing S. cerevisiae mannan exhibited normal levels of spontaneous mobility and chemotaxis in response to the synthetic cytotaxin N-formyl-methionyl-leucylphenylalanine. The latter observation was further supported by our finding that specific binding of a radiolabeled N-formyl tripeptide was not affected by the presence of S. cerevisiae mannan (data not shown). Phagocytosis-induced stimulation of the respiratory burst response, as measured by chemiluminescence and by the superoxide-mediated reduction of cytochrome c, was inhibited effectively by S. cerevisiae mannan. The levels of inhibition determined by these two assays were 51 and 44%, respectively. Phagocytosis-induced stimulation of the neutrophil secretory response was studied by measuring the release of acid phosphatase, beta-glucuronidase, lysozyme, and myeloperoxidase into the suspending medium. We found that the accumulation of myeloperoxidase in the suspending medium was inhibited in the presence of S. cerevisiae mannan by an average of 76% but that the release of the other lysosomal enzymes was not affected by this polysaccharide. Phagocytosis of zymosan appeared to be unaffected by S. cerevisiae mannan, as judged subjectively by light microscopic examinations of cells after these assays. All of the experiments described below concentrated on the mechanism of mannan-mediated release of myeloperoxidase and its possible relationship to the pathogenesis of candidoses.
To establish that the observed inhibitory effects of the commercial preparation of S. cerevisiae mannan were due to polysaccharide, we assayed this material for the presence of protein by the method of Bradford (2), using a Bio-Rad protein assay kit. We found that protein provided less than 1% of the weight of the polysaccharide. That this small amount of protein was not responsible for the inhibitory property of S. cerevisiae mannan was determined by the finding that boiling for 15 min did not affect this inhibitory property of S. cerevisiae mannan. Furthermore, the apparently selective inhibition of myeloperoxidase release could not be attributed to inhibition of myeloperoxidase enzymatic activity since the addition of S. cerevisiae mannan to myeloperoxidase released in the absence of polysaccharide did not influence the assay for myeloperoxidase activity.
To relate our results obtained with S. cerevisiae mannan to mechanisms of loss of host defense functions in candidoses, we also examined the influence of a patient-derived mannan on neutrophil respiratory and secretory functions. This mannan, which was isolated from the serum of an individual with chronic mucocutaneous candidosis, was used at a concentration of 1 mg/ml and was also inhibitory in the assays used. Figure 2 shows the results obtained in single tests of this material. The respiratory burst response as measured by chemiluminescence and reduction of cytochrome c was inhibited by 31 and 33%, respectively. Release of myeloperoxidase was inhibited by 39%. A mannan fraction obtained from the serum of a healthy donor did not influence these assays.
Influence of other mannose-derived compounds on myeloperoxidase release. To determine whether inhibition of myeloperoxidase release was a phenomenon unique to mannose polysaccharide, we assessed the abilities of other mannose-derived compounds to inhibit this neutrophil response (Fig. 3) . At Figure 4 shows that myeloperoxidase accumulated continuously in the supernatant fluid for more than 60 min after a phagocytic stimulus was added. The addition of S. cerevisiae mannan at a concentration of 1 mg/ml simultaneously with the stimulus significantly slowed the rate of accumulation of myeloperoxidase in the suspending medium.
When a high dose of S. cerevisiae mannan was added 10 or 20 min after the stimulus was added, a different pattern of inhibition of myeloperoxidase release to the suspending medium was observed. Figure 5 shows that by 10 min after S. cerevisiae mannan was added to an ongoing secretory assay reaction mixture, the myeloperoxidase activity in the supernatant fluid was decreased to a level lower than the level present at the time of introduction of the polysaccharide. These results suggested that the mechanism of influence of S. cerevisiae mannan on myeloperoxidase release may involve more than simple suppression of the neutrophil secretory response.
Carbohydrate-binding property of myeloperoxidase. Among the possible explanations for the phenomenon shown in Fig. 5 myeloperoxidase, through mannan, with the cellular fraction. To examine these possibilities further, we determined whether the addition of S.
cerevisiae mannan to a cell-free, myeloperoxidase-containing supernatant under conditions comparable to those of the release assay produced a sedimentable myeloperoxidase-S. cerevisiae mannan precipitate; it did not. We also assessed the ability of myeloperoxidase to associate with S. cerevisiae mannan bound to epoxyactivated Sepharose beads (Fig. 6) . Using myeloperoxidase released from neutrophils by sonication and purified by affinity chromatography using concanavalin A-agarose (18), we found that the enzyme could be removed from the soluble phase by adding S. cerevisiae mannanSepharose, incubating at 250C for 30 min, and centrifuging. The enzyme cosedimenting with the particulate phase retained its catalytic activity. In contrast, myeloperoxidase did not associate and sediment with the ethanolamineblocked Sepharose. The association of myeloperoxidase with S. cerevisiae mannan-Sepharose was of sufficient strength that addition of alpha-methyl-D-mannoside at a concentration of 40 mg/ml did not effect its displacement. DISCUSSION Our results demonstrate that the mannan derived from the cell walls of bakers' yeast (S. cerevisiae) differentially affects several functions of human neutrophils. Neither sponta- on September 28, 2017 by guest http://iai.asm.org/ Downloaded from neous mobility nor chemotaxis toward an Nformyl peptide was influenced by S. cerevisiae mannan. In contrast, phagocytosis-induced stimulation of the respiratory burst, as measured by two different methods, was depressed significantly by this mannan. S. cerevisiae mannan had a paradoxical influence on phagocytosis-induced release of lysosomal enzymes. The release of acid phosphatase and beta-glucuronidase from primary granules and the release of lysozyme from primary and secondary granules were not affected. However, the release of myeloperoxidase from primary granules appeared to be depressed significantly by S. cerevisiae mannan at concentrations of 0.01 to 1.0 mg/ml.
The mechanism of the inhibitory effect of S. cerevisiae mannan on the respiratory burst response remains to be determined. This effect could not be attributed to a loss of phagocytic function since a microscopic examination showed that neutrophils from the assay mixture appeared to have ingested normal numbers of zymosan particles. Furthermore, the loss of phagocytic function would also have affected the release of all lysosomal enzymes assayed, which was not observed. Since S. cerevisiae mannan also had no effect on chemotaxis and on the specific binding of a radiolabeled N-formyl tripeptide, we suspect that S. cerevisiae mannan may interfere with some event after the stimulant-neutrophil interaction. S. cerevisiae mannan-mediated inhibition of the respiratory burst response measured by two dissimilar assays would require that S. cerevisiae mannan interact with a common component. In preliminary experiments, we determined that S. cerevisiae mannan inhibits cytochrome c reduction in a noncellular system involving hypoxanthine and xanthine oxidase and does not inhibit oxygen consumption by neutrophils incubated with opsonized zymosan. These observations suggest that S. cerevisiae mannan does not affect superoxide production but, rather, may be a substrate for interaction with superoxide. Scavenging superoxide would be expected to reduce the levels of the respiratory burst response measured by both of the methods employed.
Similarly, the mechanism by which S. cerevisiae mannan selectively inhibits release of myeloperoxidase cannot involve loss of phagocytic function. Furthermore, it cannot occur through interference with degranulation per se, as the four enzymes studied are contained in total or in part in a common granular species (26) . Finally, interference exclusively with the catalytic activity of myeloperoxidase cannot explain our findings, since S. cerevisiae mannan did not influence this assay.
Our first clue to the mechanism of S. cerevi-
siae mannan-mediated inhibition of release of myeloperoxidase came from experiments in which S. cerevisiae mannan was added at different times after the secretory response was initiated. The significant finding in these experiments was that the addition of S. cerevisiae mannan did not simply produce a plateau or reduce the rate of accumulation of myeloperoxidase in the suspension medium. Instead, the enzyme activity associated with the supematant phase of the reaction was reduced to levels well below those present at the time of addition of S. cerevisiae mannan. We reasoned that this disappearance of myeloperoxidase could be due either to co-sedimentation of the enzyme with the cellular fraction or to formation of a sedimentable S. cerevisiae mannan-myeloperoxidase complex. In either case, binding of myeloperoxidase to S. cerevisiae mannan was required. Therefore, to create a model for this aspect of these mechanisms, we examined the ability of myeloperoxidase to bind to Sepharose beads to which S. cerevisiae mannan had been bound covalently.
After incubation of myeloperoxidase with S. cerevisiae mannan-Sepharose, we observed that the enzyme could be removed from the soluble phase by centrifugation and that the Sepharosebound myeloperoxidase retained its catalytic activity. The blocked form of Sepharose did not associate with appreciable enzyme activity. Thus, human neutrophil lysosomal myeloperoxidase appears to possess an ability to bind to derivatives of mannose sugars and especially to D-mannose-6-phosphate and S. cerevisiae mannan. Additional studies will be required to establish more completely the relative affinities of myeloperoxidase for other carbohydrates, the physicochemical basis ofthe carbohydrate-binding function of myeloperoxidase, and the relationship of this function to the two subunits proposed for the enzyme (9) .
The mechanism by which the S. cerevisiae inhibits the accumulation of myeloperoxidase released from stimulated neutrophils may involve the association of the mannan-enzyme complexes with neutrophils. This possibility is supported by our failure to produce a sedimentable complex after these reactants were mixed under conditions comparable to those of the release assay. Our findings also suggest that the addition of S. cerevisiae mannan to an ongoing secretory response resulted in a reduction in supernatant myeloperoxidase activity to a level below that present at the time S. cerevisiae mannan was added. An association of the complex with neutrophils would require that the cells also possess a similar carbohydrate-binding function. It is not unreasonable to expect that on September 28, 2017 by guest http://iai.asm.org/ Downloaded from neutrophils have this property, since human fibroblasts are known to possess a cell membrane lectin with an affinity for mannose-6-phosphate and related polysaccharides (11, 24) .
The ability of myeloperoxidase to bind carbohydrate may have additional significance with respect to the well-known microbicidal activity of this enzyme (13) . It seems reasonable to speculate that the binding of myeloperoxidase to microbial cell surface carbohydrates would result in generation ofhypochlorous acid and other toxic agents in close physical proximity to target components of the cells. Binding of myeloperoxidase to the cells would then minimize dilution of such agents and their interaction with alternative substrates and thus enhance killing in an extracellular environment. This possibility has been described previously by Selvaraj et al. (25) , based upon their observations and the observation of Klebanoff (14) that myeloperoxidase is adsorbed on bacterial surfaces. The former investigators provided additional evidence of the functional significance of this association by demonstrating that when myeloperoxidase and bacteria are preincubated before hydrogen peroxide is added, the potency of the bactericidal system is increased enormously (25) . We propose that the carbohydrate-binding property of myeloperoxidase provides a mechanism for this important association.
The relevance of our studies with S. cerevisiae mannan to the pathogenesis of candidosis is suggested by the results of the experiments in which we used a mannan preparation derived from the serum of a patient with chronic mucocutaneous candidosis by concanvalin A-affinity chromatography. These results illustrated that the Candida polysaccharide and S. cerevisiae mannan have comparable influences on stimulated neutrophil respiratory and secretory functions. This similarity is not totally surprising since these polysaccharides have similar compositions (22) . Our findings complement those of Laforce et al., who observed that serum from candidosis patients had an inhibitory effect on leukocyte candidicidal activity (15) . Mannan antigenemia, which is associated with candidoses (12, 28) , may then inhibit the oxidative microbicidal potential of neutrophils before phagocytosis of the organism or remove secreted myeloperoxidase from the area of infection to reduce extracellular killing of the yeast. Although it is significant that myeloperoxidase bound to S. cerevisiae mannan-Sepharose retained its catalytic function, it is also possible that the interaction of myeloperoxidase with other polysaccharides may inhibit enzyme activity. Additional work will be required to verify the nature and significance of these relationships, but we anticipate that these findings will be particularly useful in providing a basis for renewed modeling of conditions which result in loss of host defense functions and development of chronic candidoses.
